BRKR peer analysis
Bruker (BRKR) against its competitors: price, today's move, 1-year return and market value side by side.
- BRKR's peers: A (Agilent), BIO (Bio-Rad), DHR (Danaher), MTD (Mettler-Toledo), PACB (Pacific Biosciences), QGEN (QIAGEN), RVTY (Revvity), TECH (Bio-Techne).
BRKR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| A Agilent | $170.00 | -3.05% | 17.73% | $47.93B |
| BIO Bio-Rad | $358.90 | -2.34% | 17.75% | $9.65B |
| DHR Danaher | $221.31 | -2.75% | -0.49% | $155.70B |
| MTD Mettler-Toledo | $1,666.88 | -2.27% | 18.69% | $33.15B |
| PACB Pacific Biosciences | $1.63 | -7.12% | -7.12% | $510.38M |
| QGEN QIAGEN | $49.30 | -0.66% | 10.96% | $10.18B |
| RVTY Revvity | $145.10 | -4.28% | 57.29% | $16.20B |
| TECH Bio-Techne | $72.67 | -0.04% | 25.70% | $11.42B |
| TMO Thermo Fisher | $673.50 | -2.21% | 17.38% | $249.54B |
| WAT Waters | $440.45 | -3.51% | 17.06% | $43.29B |
| BRKR Bruker | $56.46 | -9.08% | 30.12% | $8.62B |